Thursday's Analysts' Upgrades and Downgrades
CHANGE IN RATINGS
Arbitron (ARB - commentary - Cramer's Take - Rating) upgraded at Bear: ARB was upgraded from Peer Perform to Outperform, Bear Stearns said. Company is making progress in its PPM rollout, which should help drive the stock.
CACI International (CAI - commentary - Cramer's Take - Rating) downgraded at Wachovia: CAI was downgraded to Market Perform, Wachovia said. Sudden departure of the CFO increases concern about the company's near-term direction.
Gol Airlines (GOL - commentary - Cramer's Take) coverage resumed at Morgan Stanley: Morgan Stanley resumes coverage of Gol Airlines with an overweight rating and a $37 price target.
Level 3 (LVLT - commentary - Cramer's Take - Rating) rated new Outperform at Credit Suisse: Credit Suisse said it is initiating coverage on LVLT with an Outperform rating. Believes company will continue to see strong demand driven by higher data usage. Sets $7.50 target price.
MetLife (MET - commentary - Cramer's Take - Rating) upgraded at UBS: MET upgraded to Buy rating from Neutral at UBS. Price target lifts to $71 from $64. 2007 eps estimates bumps to $5.27 from $5.23.
Tidewater (TDW - commentary - Cramer's Take - Rating) coverage initiated at Goldman Sachs: Goldman said it is initiating coverage on TDW with a Sell rating. See lower utilization and declining dayrates for company's old fleet. Price target at $43.
United Surgical (USPI - commentary - Cramer's Take - Rating) downgraded at Deutsche: USPI was downgraded from Buy to Hold, Deutsche Bank said. $31 price target. Do not expect the company to receive a better takeover offer before next month.
STOCK COMMENTS / EPS CHANGES
Boeing (BA - commentary - Cramer's Take - Rating) numbers raised at UBS: BA numbers raised, UBS said. Price target jumps to $82 from $76. 2007 eps estimates lift to $4.85 from $4.80. Reiterates Reduce rating.
Conoco Phillips (COP - commentary - Cramer's Take - Rating) price target cut at Goldman: Goldman said it is cutting its target on COP to $76 from $83 after company reported disappointing year-end reserve data. Believe data supports long-term strength in oil prices, and that Conoco fundamentals remain strong. Maintain Buy rating.
Genentech (DNA - commentary - Cramer's Take - Rating) price target raised at Goldman: Goldman said it is upping its target on DNA to $102 from $95 due to strong sales of Lucentis, Rituxan and Avastin. Company guidance was above both Goldman and consensus estimates. Maintained Buy rating.
Guitar Center (GTRC - commentary - Cramer's Take - Rating) estimates cut at Piper: Piper said it is cutting its 2007 estimates on GTRC to $2.74 a share due to lower expectations for top-line growth following weak Q4 sales. Maintained Outperform rating.
j2 Global (JCOM - commentary - Cramer's Take - Rating) numbers lowered: JCOM numbers lowered, Jefferies said. Price target drops to $27 from $28. 2007 eps estimates lowered to $1.50 from $1.57. Reiterates Hold rating.
Urban Outfitters (URBN - commentary - Cramer's Take - Rating) numbers raised at Piper: Piper said it is raising its target price on URBN from $17 to $28 to reflect improved earnings outlook. Maintained Market Perform rating.
Waters (WAT - commentary - Cramer's Take - Rating)numbers raised at UBS: WAT numbers raised, UBS said. Price target jumps to $57 from $52. 2007 eps estimates lift to $2.60 from $2.54. Reiterates Neutral rating.
Published by thestreet.comLabels: ARB, BA, CAI, COP, DNA, GOL, GTRC, JCOM, LVLT, MET, TDW, URBN, USPI, WAT
posted by Stock Administrator @ 10:29 AM
0 Comments
Thursday's Analysts' Upgrades and Downgrades
CHANGE IN RATINGS
Arbitron (ARB - commentary - Cramer's Take - Rating) upgraded at Bear: ARB was upgraded from Peer Perform to Outperform, Bear Stearns said. Company is making progress in its PPM rollout, which should help drive the stock.
CACI International (CAI - commentary - Cramer's Take - Rating) downgraded at Wachovia: CAI was downgraded to Market Perform, Wachovia said. Sudden departure of the CFO increases concern about the company's near-term direction.
Gol Airlines (GOL - commentary - Cramer's Take) coverage resumed at Morgan Stanley: Morgan Stanley resumes coverage of Gol Airlines with an overweight rating and a $37 price target.
Level 3 (LVLT - commentary - Cramer's Take - Rating) rated new Outperform at Credit Suisse: Credit Suisse said it is initiating coverage on LVLT with an Outperform rating. Believes company will continue to see strong demand driven by higher data usage. Sets $7.50 target price.
MetLife (MET - commentary - Cramer's Take - Rating) upgraded at UBS: MET upgraded to Buy rating from Neutral at UBS. Price target lifts to $71 from $64. 2007 eps estimates bumps to $5.27 from $5.23.
Tidewater (TDW - commentary - Cramer's Take - Rating) coverage initiated at Goldman Sachs: Goldman said it is initiating coverage on TDW with a Sell rating. See lower utilization and declining dayrates for company's old fleet. Price target at $43.
United Surgical (USPI - commentary - Cramer's Take - Rating) downgraded at Deutsche: USPI was downgraded from Buy to Hold, Deutsche Bank said. $31 price target. Do not expect the company to receive a better takeover offer before next month.
STOCK COMMENTS / EPS CHANGES
Boeing (BA - commentary - Cramer's Take - Rating) numbers raised at UBS: BA numbers raised, UBS said. Price target jumps to $82 from $76. 2007 eps estimates lift to $4.85 from $4.80. Reiterates Reduce rating.
Conoco Phillips (COP - commentary - Cramer's Take - Rating) price target cut at Goldman: Goldman said it is cutting its target on COP to $76 from $83 after company reported disappointing year-end reserve data. Believe data supports long-term strength in oil prices, and that Conoco fundamentals remain strong. Maintain Buy rating.
Genentech (DNA - commentary - Cramer's Take - Rating) price target raised at Goldman: Goldman said it is upping its target on DNA to $102 from $95 due to strong sales of Lucentis, Rituxan and Avastin. Company guidance was above both Goldman and consensus estimates. Maintained Buy rating.
Guitar Center (GTRC - commentary - Cramer's Take - Rating) estimates cut at Piper: Piper said it is cutting its 2007 estimates on GTRC to $2.74 a share due to lower expectations for top-line growth following weak Q4 sales. Maintained Outperform rating.
j2 Global (JCOM - commentary - Cramer's Take - Rating) numbers lowered: JCOM numbers lowered, Jefferies said. Price target drops to $27 from $28. 2007 eps estimates lowered to $1.50 from $1.57. Reiterates Hold rating.
Urban Outfitters (URBN - commentary - Cramer's Take - Rating) numbers raised at Piper: Piper said it is raising its target price on URBN from $17 to $28 to reflect improved earnings outlook. Maintained Market Perform rating.
Waters (WAT - commentary - Cramer's Take - Rating)numbers raised at UBS: WAT numbers raised, UBS said. Price target jumps to $57 from $52. 2007 eps estimates lift to $2.60 from $2.54. Reiterates Neutral rating.
Published by thestreet.com
Arbitron (ARB - commentary - Cramer's Take - Rating) upgraded at Bear: ARB was upgraded from Peer Perform to Outperform, Bear Stearns said. Company is making progress in its PPM rollout, which should help drive the stock.
CACI International (CAI - commentary - Cramer's Take - Rating) downgraded at Wachovia: CAI was downgraded to Market Perform, Wachovia said. Sudden departure of the CFO increases concern about the company's near-term direction.
Gol Airlines (GOL - commentary - Cramer's Take) coverage resumed at Morgan Stanley: Morgan Stanley resumes coverage of Gol Airlines with an overweight rating and a $37 price target.
Level 3 (LVLT - commentary - Cramer's Take - Rating) rated new Outperform at Credit Suisse: Credit Suisse said it is initiating coverage on LVLT with an Outperform rating. Believes company will continue to see strong demand driven by higher data usage. Sets $7.50 target price.
MetLife (MET - commentary - Cramer's Take - Rating) upgraded at UBS: MET upgraded to Buy rating from Neutral at UBS. Price target lifts to $71 from $64. 2007 eps estimates bumps to $5.27 from $5.23.
Tidewater (TDW - commentary - Cramer's Take - Rating) coverage initiated at Goldman Sachs: Goldman said it is initiating coverage on TDW with a Sell rating. See lower utilization and declining dayrates for company's old fleet. Price target at $43.
United Surgical (USPI - commentary - Cramer's Take - Rating) downgraded at Deutsche: USPI was downgraded from Buy to Hold, Deutsche Bank said. $31 price target. Do not expect the company to receive a better takeover offer before next month.
STOCK COMMENTS / EPS CHANGES
Boeing (BA - commentary - Cramer's Take - Rating) numbers raised at UBS: BA numbers raised, UBS said. Price target jumps to $82 from $76. 2007 eps estimates lift to $4.85 from $4.80. Reiterates Reduce rating.
Conoco Phillips (COP - commentary - Cramer's Take - Rating) price target cut at Goldman: Goldman said it is cutting its target on COP to $76 from $83 after company reported disappointing year-end reserve data. Believe data supports long-term strength in oil prices, and that Conoco fundamentals remain strong. Maintain Buy rating.
Genentech (DNA - commentary - Cramer's Take - Rating) price target raised at Goldman: Goldman said it is upping its target on DNA to $102 from $95 due to strong sales of Lucentis, Rituxan and Avastin. Company guidance was above both Goldman and consensus estimates. Maintained Buy rating.
Guitar Center (GTRC - commentary - Cramer's Take - Rating) estimates cut at Piper: Piper said it is cutting its 2007 estimates on GTRC to $2.74 a share due to lower expectations for top-line growth following weak Q4 sales. Maintained Outperform rating.
j2 Global (JCOM - commentary - Cramer's Take - Rating) numbers lowered: JCOM numbers lowered, Jefferies said. Price target drops to $27 from $28. 2007 eps estimates lowered to $1.50 from $1.57. Reiterates Hold rating.
Urban Outfitters (URBN - commentary - Cramer's Take - Rating) numbers raised at Piper: Piper said it is raising its target price on URBN from $17 to $28 to reflect improved earnings outlook. Maintained Market Perform rating.
Waters (WAT - commentary - Cramer's Take - Rating)numbers raised at UBS: WAT numbers raised, UBS said. Price target jumps to $57 from $52. 2007 eps estimates lift to $2.60 from $2.54. Reiterates Neutral rating.
Published by thestreet.com
Labels: ARB, BA, CAI, COP, DNA, GOL, GTRC, JCOM, LVLT, MET, TDW, URBN, USPI, WAT
posted by Stock Administrator @ 10:29 AM
0 Comments
